Literature DB >> 366781

Xipamide in the management of renal, hepatic and cardiac oedema.

C H Gold, M Viljoen.   

Abstract

Xipamide (4-chloro-5-sulphamyl-salicylic acid 2', 6'-dimethylanilide) is a diuretic and antihypertensive agent. A clinical trial of the drug was performed in 11 patients, 8 with nephrotic syndrome, 1 with oedema and ascites due to hepatic cirrhosis, and 2 with congestive cardiac failure due to idiopathic cardiomyopathy. The drug proved to be potent, safe and efficacious. Side-effects were similar to those encountered with other thiazide-derived diuretics, but were not of a severe nature. Wider clinical usage of xipamide would appear to be warranted.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 366781

Source DB:  PubMed          Journal:  S Afr Med J


  2 in total

Review 1.  Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  B N Prichard; R N Brogden
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

2.  Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.